David R Stevens
CIK 1292382 · last filed 2023-05-12
David R Stevens is a corporate insider who has filed 29 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider bought $20.8K of AMPE on May 12, 2023. Across all open-market trades the lifetime net is +$82.9K, making them a net buyer over the disclosed history. 23 SEC filings were submitted jointly with Ampio Pharmaceuticals, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PARDD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 500
SEATTLE, WA 98119-4114
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Director | 1,699 | $0.18 | $311 | $20.8K | 22 | 2023-05-12 |
| PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Director | 55,963 | — | — | $62.2K | 7 | 2011-06-10 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-12 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Buy (P) | +95,000 | $20.8K | EDGAR |
| 2022-01-03 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-15 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-05 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Grant (A) | +13,513 | $20.0K | EDGAR |
| 2020-12-15 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-06 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Grant (A) | +34,059 | $20.0K | EDGAR |
| 2019-12-23 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-11 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Mixed | — | $0 | EDGAR |
| 2019-01-09 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-04 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Grant (A) | +45,454 | $20.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.